AzurRx BioPharma, Inc. (20)
Browse by Contract Category
Contracts
-
Form of Wainwright Warrant
(Filed With SEC on March 10, 2021)
-
License Agreement, dated December 31, 2020, by and between the Company and First Wave Bio, Inc
(Filed With SEC on January 13, 2021)
-
Employment Agreement by and between AzurRx BioPharma, Inc. and Mr. Schneiderman, dated January 1, 2020
(Filed With SEC on January 6, 2020)
-
Selling Agent Agreement, by and between AzurRx BioPharma, Inc. and Alexander Capital, L.P., dated May 9, 2019
(Filed With SEC on May 14, 2019)
-
Form of Warrant
(Filed With SEC on March 10, 2021)
-
Form of Wainwright Warrant
(Filed With SEC on January 8, 2021)
-
Employment Agreement by and between AzurRx BioPharma, Inc. and James Sapirstein, dated October 8, 2019
(Filed With SEC on October 11, 2019)
-
Form of Wainwright Warrant
(Filed With SEC on July 22, 2019)
-
Underwriting Agreement, dated July 17, 2019
(Filed With SEC on July 22, 2019)
-
Form of Selling Agent Warrant
(Filed With SEC on May 14, 2019)
-
Selling Agent Agreement, by and between AzurRx BioPharma, Inc. and Alexander Capital, L.P., dated April 1, 2019
(Filed With SEC on April 3, 2019)
-
Form of Selling Agent Warrant
(Filed With SEC on April 3, 2019)
-
Patent License Agreement, by and betweenAzurRxBioPharma, Inc. andLaboratoiresMayolySpindler SAS, dated March 27, 2019
(Filed With SEC on April 1, 2019)
-
AssetPurchaseAgreement, by and betweenAzurRxBioPharma, Inc.,AzurRxBioPharmaSAS andLaboratoiresMayolySpindler SAS, dated March 27, 2019
(Filed With SEC on April 1, 2019)
-
Senior Convertible Note A, dated February 14, 2019
(Filed With SEC on February 20, 2019)
-
Registration Rights Agreement, dated February 14, 2019
(Filed With SEC on February 20, 2019)
-
Warrant Amendment Agreement, dated February 14, 2019
(Filed With SEC on February 20, 2019)
-
Form of Pledge Agreement, dated February 14, 2019
(Filed With SEC on February 20, 2019)
-
Senior Convertible Note B, dated February 14, 2019
(Filed With SEC on February 20, 2019)
-
Note Purchase Agreement, dated February 14, 2019
(Filed With SEC on February 20, 2019)
